Krystal Biotech, Inc. (KRYS)
316.58
-13.42
(-4.07%)
USD |
NASDAQ |
Oct 16, 16:00
316.81
+0.23
(+0.07%)
After-Hours: 20:00
Krystal Biotech Free Cash Flow : 257.78M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 257.78M |
| March 31, 2026 | 237.38M |
| December 31, 2025 | 188.91M |
| September 30, 2025 | 165.59M |
| June 30, 2025 | 185.44M |
| March 31, 2025 | 129.32M |
| December 31, 2024 | 119.18M |
| September 30, 2024 | 58.06M |
| June 30, 2024 | -22.76M |
| March 31, 2024 | -54.44M |
| December 31, 2023 | -100.60M |
| September 30, 2023 | -119.07M |
| June 30, 2023 | -129.81M |
| March 31, 2023 | -152.40M |
| December 31, 2022 | -153.55M |
| September 30, 2022 | -187.78M |
| June 30, 2022 | -182.29M |
| March 31, 2022 | -136.83M |
| December 31, 2021 | -116.27M |
| September 30, 2021 | -69.72M |
| Date | Value |
|---|---|
| June 30, 2021 | -52.42M |
| March 31, 2021 | -45.32M |
| December 31, 2020 | -40.93M |
| September 30, 2020 | -35.02M |
| June 30, 2020 | -29.49M |
| March 31, 2020 | -27.66M |
| December 31, 2019 | -25.11M |
| September 30, 2019 | -20.61M |
| June 30, 2019 | -17.96M |
| March 31, 2019 | -14.56M |
| December 31, 2018 | -11.74M |
| September 30, 2018 | -9.207M |
| June 30, 2018 | -7.545M |
| March 31, 2018 | -6.205M |
| December 31, 2017 | -4.10M |
| September 30, 2017 | -2.684M |
| June 30, 2017 | -1.886M |
| March 31, 2017 | -1.59M |
| December 31, 2016 | -1.326M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| TG Therapeutics, Inc. | 17.38M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Cytokinetics, Inc. | -580.72M |
| Exelixis, Inc. | 1.172B |
| Ionis Pharmaceuticals, Inc. | -567.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 74.79M |
| Cash from Investing (Quarterly) | -161.58M |
| Cash from Financing (Quarterly) | 15.05M |
| Free Cash Flow Per Share (Quarterly) | 2.323 |
| Free Cash Flow to Equity (Quarterly) | 71.48M |
| Free Cash Flow to Firm (Quarterly) | 71.22M |
| Free Cash Flow Yield | 2.69% |